BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26224509)

  • 1. Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study.
    Iachetta F; Domati F; Reggiani-Bonetti L; Barresi V; Magnani G; Marcheselli L; Cirilli C; Pedroni M
    Intern Emerg Med; 2016 Feb; 11(1):41-6. PubMed ID: 26224509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
    Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
    Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in sporadic colon cancer with high-level microsatellite instability.
    Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
    Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
    Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.
    Tikidzhieva A; Benner A; Michel S; Formentini A; Link KH; Dippold W; von Knebel Doeberitz M; Kornmann M; Kloor M
    Br J Cancer; 2012 Mar; 106(6):1239-45. PubMed ID: 22353804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.
    Sinicrope FA; Rego RL; Foster N; Sargent DJ; Windschitl HE; Burgart LJ; Witzig TE; Thibodeau SN
    Am J Gastroenterol; 2006 Dec; 101(12):2818-25. PubMed ID: 17026563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
    Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
    Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIMP status of interval colon cancers: another piece to the puzzle.
    Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A
    Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator for adjuvant therapy in colon cancer.
    Kumar S; Chang EY; Frankhouse J; Dorsey PB; Lee RG; Johnson N
    Arch Surg; 2009 Sep; 144(9):835-40. PubMed ID: 19797108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
    Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
    Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
    Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
    Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
    Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
    Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection.
    An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH
    Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
    Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
    Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic characteristics of colorectal cancer with microsatellite instability.
    Ziadi S; Ksiaa F; Ben Gacem R; Labaied N; Mokni M; Trimeche M
    Pathol Res Pract; 2014 Feb; 210(2):98-104. PubMed ID: 24286815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
    Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
    Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.